An empirical approach to the definition of the target margins in eye radiosurgery.
CBCT
eye tracking
planning target volume
stereotactic radiosurgery
uveal melanoma
Journal
Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
revised:
10
03
2023
received:
30
11
2022
accepted:
20
03
2023
medline:
7
8
2023
pubmed:
4
7
2023
entrez:
4
7
2023
Statut:
ppublish
Résumé
A system for stabilizing and monitoring eye movements during LINAC-based photon beam one single fraction stereotactic radiotherapy was developed at our Institution. This study aimed to describe the feasibility and the efficacy of our noninvasive optical localization system that was developed, tested, and applied in 20 patients treated for uveal melanoma. Our system consisted of a customized thermoplastic mask to immobilize the head, a gaze fixation LED, and a digital micro-camera. The localization procedure, which required the active collaboration of the patient, served to monitor the eye movements during all phases of the treatment, starting from the planning computed tomography up to the administration of radiotherapy, and allowed the operators to suspend the procedure and to interact with the patient in case of large movements of the pupil. Twenty patients were treated with stereotactic radiosurgery (27 Gy in one fraction) for primary uveal melanoma. All patients showed a good tolerance to the treatment; until now, all patients were in local control during the follow up and one died for distant progression 6 months after radiosurgery. This study showed that this noninvasive technique, based on eye position control, is appropriate and can contribute to the success of LINAC-based stereotactic radiotherapy. A millimetric safety margin to the clinical target volume was adequate to take account for the organ movement. All patients treated till now showed a good local control; failures in the disease control were due to metastatic spread.
Identifiants
pubmed: 37401002
doi: 10.1002/acm2.13982
pmc: PMC10402678
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13982Informations de copyright
© 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.
Références
Radiat Oncol. 2018 Aug 2;13(1):140
pubmed: 30071857
Med Phys. 2013 Dec;40(12):121715
pubmed: 24320501
Cureus. 2022 Feb 7;14(2):e21996
pubmed: 35282559
Sci Rep. 2021 Mar 11;11(1):5685
pubmed: 33707492
Med Dosim. 2016 Autumn;41(3):199-204
pubmed: 26994824
J Radiat Res. 2017 May 1;58(3):386-396
pubmed: 27811199
Australas Phys Eng Sci Med. 2017 Jun;40(2):433-439
pubmed: 28466444
Transl Cancer Res. 2020 Oct;9(10):6005-6012
pubmed: 35117212
Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1128-36
pubmed: 12829151
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1121-35
pubmed: 10863086
Brachytherapy. 2014 Jan-Feb;13(1):1-14
pubmed: 24373763
Sci Rep. 2020 Jul 9;10(1):11297
pubmed: 32647177
J Appl Clin Med Phys. 2002 Summer;3(3):176-89
pubmed: 12132939
Technol Cancer Res Treat. 2017 Jun;16(3):352-356
pubmed: 28168935
Oman J Ophthalmol. 2013 May;6(2):116-8
pubmed: 24082672
Med Phys. 2009 Mar;36(3):719-24
pubmed: 19378732
Stereotact Funct Neurosurg. 2017;95(6):363-368
pubmed: 29131131
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4666-73
pubmed: 17065472
J Appl Clin Med Phys. 2003 Spring;4(2):156-61
pubmed: 12777151
Radiother Oncol. 2001 Oct;61(1):49-56
pubmed: 11578728
J Appl Clin Med Phys. 2023 Aug;24(8):e13982
pubmed: 37401002
Lancet Oncol. 2020 Nov;21(11):1526-1536
pubmed: 33152286
Cureus. 2016 Apr 21;8(4):e582
pubmed: 27226942